The Personalized Medicine Market is the most recent trend in the multibillion–dollar molecular diagnostics industry. Pharmaceutical and biotechnology companies are increasingly turning to personalized medicine in order to improve the drug development process and also to speed up the approval or sanction of new drugs.
Get Sample Copy @
According to the industry consensus, personalized medicine will not only form an integral part of typical medicine in the next few years, it is also anticipated to reform the development, testing, marketing and prescription of drugs during the next decade. The big pharmaceutical companies eventually will change their tried and tested epic business model to more–targeted and effective healthcare solutions. U.S personalized medicine market is expected to grow at the CAGR of 7.5% during the forecasted period.
Key players of U.S. Personalized Medicine Market:
- Laboratory Corporation of America
- Quest Diagnostics
- Becton Dickinson & Co.
- Siemens Healthcare Diagnostics Inc.
- GE Healthcare
- Pfizer Inc.
- CardioDx Inc.
- Asuragen Inc.
- Bristol-Myers Squibb
The U.S. Personalized Medicine Market is segmented on the basis of product, application and end users. Based on the product, the market has been segmented as diagnostic, therapeutics, medical care and nutrition and wellness and others. Based on application, the market has been segmented into diagnosis and intervention, drug development and usage, cancer genomics and others. Further on the basis of end users the market has been segmented as hospitals, molecular diagnostic laboratories and testing centers, academic institutes, bio and health informatics companies and others.
U.S. accounts for the maximum market share of the personalized medicine market and the market is expected to increase continuously in coming years. This can be attributed to increasing pool of cancer patients along with high healthcare per capita expenditure. Advancing technologies within the liquid biopsy or cancer market is also driving the market and will see strategic growth over the next five years. The two segments of the liquid biopsy market are tumor cell enrichment products and tumor cell detection technologies which are expected to command the maximum market share.
Browse Complete 110 Pages Premium Research Report Enabled with 77 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/personalized-medicine-market-2937
Detailed Table of Contents:
Table Of Contents
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
3.4 Macroeconomic Indicators
List Of Tables and Figures
List Of Tables
Table 1 U.S. Personalised Medicine Market, By Product, 2017-2023 (Usd Million)
Table 2 U.S. Personalised Medicine Market, By Application, 2017-2023 (Usd Million)
Table 3 U.S. Personalised Medicine Marketby End Users 2017-2023 (Usd Million)
Table 4 U.S. Personalised Medicine Market, By Region 2017-2023 (Usd Million)
List Of Figures
Figure 1 Research Process
Figure 2 Porters Five Forces Model
Figure 3 U.S. Personalised Medicine Market, By Product
Figure 4 U.S. Personalised Medicine Market, By Application
Figure 5 U.S. Personalised Medicine Market, By End Users
Figure 6 U.S. Personalised Medicine Market, By Region
Figure 7 U.S. Personalised Medicine Market: Company Share Analysis, 2016 (%)
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312